Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial

Alan J. Kivitz, Maria W. Greenwald, Stanley B. Cohen, Adam B. Polis, Daryl K. Najarian, Mary E. Dixon, Robert A. Moidel, Jerry A. Green, Herbert S.B. Baraf, Richard A. Petruschke, Alan K. Matsumoto, Gregory P. Geba

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and Safety of Rofecoxib 12.5 mg Versus Nabumetone 1,000 mg in Patients with Osteoarthritis of the Knee: A Randomized Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences